| scholarly article | Q13442814 |
| P50 | author | Xiaoming He | Q42592643 |
| Hai Wang | Q56929166 | ||
| P2093 | author name string | Xiongbin Lu | |
| Jianhua Yu | |||
| Pranay Agarwal | |||
| Shuting Zhao | |||
| Ronald X Xu | |||
| P2860 | cites work | Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities | Q24322851 |
| The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 | Q24617130 | ||
| Cancer stem cells and drug resistance: the potential of nanomedicine | Q26998993 | ||
| DNA topoisomerases and their poisoning by anticancer and antibacterial drugs | Q28284744 | ||
| Cancer stem cells in solid tumours: accumulating evidence and unresolved questions | Q28293535 | ||
| Topoisomerase I inhibitors: camptothecins and beyond | Q29614976 | ||
| EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer | Q29616360 | ||
| Cancer drug resistance: an evolving paradigm | Q29616694 | ||
| Nanocarriers as an emerging platform for cancer therapy | Q29616699 | ||
| Supercoiling of the DNA template during transcription | Q29617503 | ||
| Assessing the in vivo efficacy of doxorubicin loaded hyaluronan nanoparticles | Q30570691 | ||
| Mechanics of receptor-mediated endocytosis | Q33892369 | ||
| Polymer-Based Nitric Oxide Therapies: Recent Insights for Biomedical Applications | Q33951477 | ||
| Thermally responsive nanoparticle-encapsulated curcumin and its combination with mild hyperthermia for enhanced cancer cell destruction | Q34061502 | ||
| Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. | Q34447986 | ||
| Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity | Q35009843 | ||
| Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells | Q35156211 | ||
| Enhanced enrichment of prostate cancer stem-like cells with miniaturized 3D culture in liquid core-hydrogel shell microcapsules | Q35514837 | ||
| Breast cancer stem cells, cytokine networks, and the tumor microenvironment | Q35571904 | ||
| Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts | Q35855107 | ||
| CD44 in cancer progression: adhesion, migration and growth regulation | Q35875561 | ||
| In vitro transcription of eukaryotic genes is affected differently by the degree of DNA supercoiling | Q37484981 | ||
| Cancer stem cells: cell culture, markers, and targets for new therapies | Q37598736 | ||
| Nanoparticle-based combination therapy toward overcoming drug resistance in cancer | Q37979618 | ||
| Nanoparticle-assisted combination therapies for effective cancer treatment. | Q38027852 | ||
| Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery | Q38082172 | ||
| Cytokines driving breast cancer stemness | Q38096720 | ||
| Engineered nanoparticles for drug delivery in cancer therapy | Q38258048 | ||
| Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles | Q38998501 | ||
| ATP-triggered anticancer drug delivery | Q39016466 | ||
| Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance. | Q39065382 | ||
| Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles | Q39496907 | ||
| Synthesis and characterization of thermally responsive Pluronic F127-chitosan nanocapsules for controlled release and intracellular delivery of small molecules. | Q39637577 | ||
| The encapsulation and intracellular delivery of trehalose using a thermally responsive nanocapsule. | Q39837519 | ||
| Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention | Q40367017 | ||
| iRGD-coupled responsive fluorescent nanogel for targeted drug delivery | Q44967142 | ||
| Size of IgG-opsonized particles determines macrophage response during internalization | Q47285262 | ||
| Chitosan-Decorated Doxorubicin-Encapsulated Nanoparticle Targets and Eliminates Tumor Reinitiating Cancer Stem-like Cells. | Q50973329 | ||
| A mechanistic, predictive model of dose-response curves for cell cycle phase-specific and -nonspecific drugs. | Q52080713 | ||
| The role of DNA topoisomerases in recombination and genome stability: a double-edged sword? | Q54710073 | ||
| Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice | Q67486552 | ||
| Synergistic effect of inhibitors of topoisomerase I and II on chromosome damage and cell killing in cultured Chinese hamster ovary cells | Q72149439 | ||
| Phase II study of irinotecan plus doxorubicin for early recurrent or platinum-refractory ovarian cancer: interim analysis | Q79753719 | ||
| Cancer stem cells | Q80312237 | ||
| P921 | main subject | doxorubicin | Q18936 |
| nanoparticle | Q61231 | ||
| irinotecan | Q412197 | ||
| P304 | page(s) | 74-89 | |
| P577 | publication date | 2015-08-29 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells | |
| P478 | volume | 72 |
| Q38635798 | A 3D-Engineered Conformal Implant Releases DNA Nanocomplexs for Eradicating the Postsurgery Residual Glioblastoma |
| Q47127845 | A Laser-Activated Biocompatible Theranostic Nanoagent for Targeted Multimodal Imaging and Photothermal Therapy |
| Q41519875 | A Nano-In-Micro System for Enhanced Stem Cell Therapy of Ischemic Diseases. |
| Q35856410 | A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents. [Corrected] |
| Q37500094 | A novel double-targeted nondrug delivery system for targeting cancer stem cells. |
| Q99565149 | A pH-Sensitive Prodrug Nanocarrier Based on Diosgenin for Doxorubicin Delivery to Efficiently Inhibit Tumor Metastasis |
| Q26738335 | Bioerodable PLGA-Based Microparticles for Producing Sustained-Release Drug Formulations and Strategies for Improving Drug Loading |
| Q47283159 | Biomaterials-Based Approaches to Tumor Spheroid and Organoid Modeling. |
| Q47642768 | Co-Delivery of Drugs and Genes Using Polymeric Nanoparticles for Synergistic Cancer Therapeutic Effects |
| Q47808831 | Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy |
| Q90270928 | Cockle Shell-Derived Aragonite CaCO3 Nanoparticles for Co-Delivery of Doxorubicin and Thymoquinone Eliminates Cancer Stem Cells |
| Q36012912 | Combined cancer therapy with hyaluronan-decorated fullerene-silica multifunctional nanoparticles to target cancer stem-like cells |
| Q42280449 | Delivery of antagomiR204-conjugated gold nanoparticles from PLGA sheets and its implication in promoting osseointegration of titanium implant in type 2 diabetes mellitus |
| Q37330473 | Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance |
| Q37639772 | Drug-Loaded Polymeric Nanoparticles for Cancer Stem Cell Targeting |
| Q90741955 | Dual drug-loaded biodegradable Janus particles for simultaneous co-delivery of hydrophobic and hydrophilic compounds |
| Q57024281 | Dual-modified cationic liposomes loaded with paclitaxel and survivin siRNA for targeted imaging and therapy of cancer stem cells in brain glioma |
| Q57350148 | Enhanced cancer therapy with cold-controlled drug release and photothermal warming enabled by one nanoplatform |
| Q57342234 | Facile fabrication of double-walled polymeric hollow spheres with independent temperature and pH dual-responsiveness for synergetic drug delivery |
| Q90353974 | HPV Oncogene Manipulation Using Nonvirally Delivered CRISPR/Cas9 or Natronobacterium gregoryi Argonaute |
| Q37625848 | Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells |
| Q41383019 | Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy |
| Q55215311 | Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy. |
| Q48018893 | Microfluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug Discovery |
| Q57066627 | Multifunctional Cargo-Free Nanomedicine for Cancer Therapy |
| Q48209273 | Nanocarrier based approaches for targeting breast cancer stem cells. |
| Q41483629 | Nanomedicine applications in the treatment of breast cancer: current state of the art. |
| Q51611875 | Nanoparticle systems reduce systemic toxicity in cancer treatment. |
| Q90554920 | Nanoparticles for Targeted Drug Delivery to Cancer Stem Cells and Tumor |
| Q38836010 | Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy |
| Q55365459 | Overcoming Ovarian Cancer Drug Resistance with a Cold Responsive Nanomaterial. |
| Q64089233 | Polymeric Co-Delivery Systems in Cancer Treatment: An Overview on Component Drugs' Dosage Ratio Effect |
| Q90694715 | Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy |
| Q38664820 | Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy |
| Q64239341 | Self-Assembly of Temperature Sensitive Unilamellar Vesicles by a Blend of Block Copolymers in Aqueous Solution |
| Q50045699 | Stimuli-responsive chitosan-based nanocarriers for cancer therapy |
| Q28071773 | Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses |
| Q37708056 | Targeted delivery of doxorubicin by nano-loaded mesenchymal stem cells for lung melanoma metastases therapy |
| Q47622098 | Targeted inhibition of human hematological cancers in vivo by doxorubicin encapsulated in smart lipoic acid-crosslinked hyaluronic acid nanoparticles |
| Q49304018 | Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance. |
| Q58568282 | Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer |
| Q38928173 | Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives |
| Q48308048 | Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies |
| Q38809044 | The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer |
| Q41144398 | Transformable DNA nanocarriers for plasma membrane targeted delivery of cytokine |
Search more.